Subdivision
• | 101. Astronomy |
(2)
| • | 102. Chemistry and Chemical Biochemistry |
(3)
| • | 103. Engineering |
(2)
| • | 104. Mathematics |
(2)
| • | 106. Physics |
(1)
| • | 201. Molecular Biology and Biochemistry |
(2)
| • | 202. Cellular and Developmental Biology |
(1)
| • | 204. Medicine, Surgery, Pathology and Immunology |
(2)
| • | 205. Microbiology |
(1)
| • | 209. Neurobiology |
(3)
| • | 302. Economics |
(1)
| • | 303. History Since 1715 |
(5)
| • | 402a |
(1)
| • | 404. History of the Arts, Literature, Religion and Sciences |
(3)
| • | 404a |
(2)
| • | 404c |
(1)
| • | 406. Linguistics |
(1)
| • | 501. Creative Artists |
(1)
| • | 502. Physicians, Theologians, Lawyers, Jurists, Architects, and Members of Other Professions |
(1)
| • | 503. Administrators, Bankers and Opinion Leaders from the Public or Private Sectors |
(9)
|
| 41 | Name: | Dr. Michael Sela | | Institution: | Weizmann Institute of Science | | Year Elected: | 1995 | | Class: | 2. Biological Sciences | | Subdivision: | 209. Neurobiology | | Residency: | International | | Living? : |
Deceased
| | Birth Date: | 1924 | | Death Date: | May 27, 2022 | | | | | One of the world's leading chemical immunologists, Michael Sela is the W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science. During his tenure at the Institute, which began in 1963, he has served as Dean of the Faculty of Biology (1970-73), as President (1975-85) and as Deputy Chair of the Board of Governors (1985-94). Considered a premier ambassador for Israeli science, Dr. Sela has most successfully applied his understanding of proteins and synthetic amino acid polymers to the manipulation of the immune system. He has also been responsible for the design and production of the specific immunogenic molecule "COP 1," which has positive actions in counteracting the autoimmune process in multiple sclerosis. Dr. Sela's scientific contributions have been recognized internationally by major honors and prizes, including the Warburg (1968), Landsteiner (1986) and UNESCO Albert Einstein (1995) Medals, the German Order of Merit and the French Legion d'Honeur. He is a member of the Max-Planck-Society, the Israel Academy of Sciences and Humanities the American Academy of Arts & Sciences and the National Academies of the U.S., France, Russia, Germany, Vatican, Romania, and Italy, and a recipient of nine honorary doctorates from the USA, Mexico, France and Israel. He received his Ph.D. from the Hebrew University in 1954. | |
42 | Name: | Mr. Isaac Stern | | Institution: | Carnegie Hall | | Year Elected: | 1995 | | Class: | 5. The Arts, Professions, and Leaders in Public & Private Affairs | | Subdivision: | 501. Creative Artists | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1920 | | Death Date: | September 22, 2001 | | | |
43 | Name: | Dr. Gilbert Stork | | Institution: | Columbia University | | Year Elected: | 1995 | | Class: | 1. Mathematical and Physical Sciences | | Subdivision: | 102. Chemistry and Chemical Biochemistry | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1921 | | Death Date: | October 21, 2017 | | | | | Gilbert Stork received a Ph.D. in chemistry at the University of Wisconsin in 1945. He was an assistant professor at Harvard University until 1953, when he moved to Columbia University for a career spanning four decades. He became Eugene Higgins Professor of Chemistry Emeritus in 1992, but continued to work up to his death on October 21, 2017, at age 95. Gilbert Stork was a world leader in the art and science of synthetic organic chemistry. Not only had he achieved trail-blazing syntheses of complex natural products of biochemical interest, such as cantharidin, lupeol, prostaglandins, steroids, reserpine and calictriol, but at the same time, he had developed many synthetic methodologies of wide applicability. Of special note is the inspiration and training he provided in his laboratory for students and postdoctoral fellows who went on to important academic and industrial positions worldwide. Dr. Stork received many honors for his work, including the American Chemical Society Award in Pure Chemistry (1957), Baekeland Medal (1961), Edward Curtis Franklin Memorial Award from Stanford (1966), American Chemical Society Award in Synthetic Organic Chemistry (1967), Roussel Prize in Steroid Chemistry (1978), Nichols Medal (1980), Arthur C. Cope Award (1980), National Medal of Science (1982), Edgar Fahs Smith Award (1982), Willard Gibbs Medal (1982), Linus Pauling Award (1983), Roger Adams Award in Organic Chemistry from the American Chemical Society (1991), the Welch Prize in Chemistry (1993), the Wolf Prize (1996), the Philadelphia Organic Chemists' Club Award (1998), the First Barton gold medal of the Royal Society of Chemistry (2002), the Ryoji Noyori Prize (2004) and the Herbert Brown Award for Creative Research in Synthetic Methods (2005). He wss an elected member of the National Academy of Sciences, the American Academy of Arts & Sciences, the Académie des Sciences (France), the Royal Society of Chemistry, (U.K.), and the Royal Society (U.K.). He was elected a member of the American Philosophical Society in 1995. | |
44 | Name: | Dr. Bert Vogelstein | | Institution: | Howard Hughes Medical Institute & Johns Hopkins Oncology Center | | Year Elected: | 1995 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Living
| | Birth Date: | 1949 | | | | | Bert Vogelstein stands out among the leading contemporary workers in the field of the molecular genetic basis of cancer, with his work in the area of colorectal cancer of particular note. He has effectively proven the multi-step process of carcinogenesis from benign adenoma to metastasizing cancer, and he identified mutations in the APC gene as an early and very frequent change in sporadic colon cancer as well as a constitutional change in persons with familial polyps of the colon. He was also responsible for defining a new type of cancer-producing gene mutation, mapping to chromosome 2, in familial colon cancer, and for identifying a specific oncogene in gliomas (brain tumors). Dr. Vogelstein's contributions are of the greatest importance for understanding the progression of malignancy, for early diagnosis of cancer, and for prevention of cancer.
Currently Clayton Professor of Oncology at the Johns Hopkins Oncology Center as well as an investigator at the Howard Hughes Medical Institute, he has been affiliated with Johns Hopkins University since receiving his Ph.D. from that institution in 1974. Dr. Vogelstein's many awards include the Alison Eberlein Award for Outstanding Contributions to Leukemia Research (1968), the Gairdner Foundation International Award in Science (1992), the American Cancer Society's Medal of Honor (1992), the Richard Lounsbery Award of the National Academy of Sciences, to whose membership he was elected in 1992, the Charles Rodophe Brupbacher Prize for Cancer Research (2012), the Breakthrough Prize in Life Sciences (2013), the Dr. Paul Janssen Award for Biomedical Research (2015),and the Gruber Genetics Prize (2019). He is also a member of the National Cancer Institute and the American Academy of Arts & Sciences. | |
| |